Trials / Unknown
UnknownNCT01493466
Serum Proteomics Analysis for Sepsis
Serum Proteomics Analysis for Dynamic Changes of Differential Proteins in Sepsis Patient With iTRAQ Labeling and LC-MS/MS
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Serum proteomics is a very useful tool to identify various disease. The purpose of the present study was to find differential proteins among patient with normal, SIRS, sepsis, severe sepsis, death and to screen potential biomarkers for their dynamic changes. Serum proteins were identified by iTRAQ labeling and LC-MS/MS. The bioinformatics analysis was performed with the Mascot software and the International Protein Index (IPI) and the Gene Ontology (GO) Database and KEGG pathway Database. The differentially expressed proteins were verified by Western blot by another sample collected from clinical.
Conditions
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-12-16
- Last updated
- 2011-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01493466. Inclusion in this directory is not an endorsement.